Page last updated: 2024-11-04

sulfasalazine and Right Ventricular Dysfunction

sulfasalazine has been researched along with Right Ventricular Dysfunction in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"Of 51 MCTD patients, 20 had pulmonary arterial hypertension (PAH) in the past 2 years."1.34Diastolic function of the heart in mixed connective tissue disease. ( Bodolay, E; Hegedus, I; Szegedi, G; Végh, J; Zeher, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Végh, J1
Hegedus, I1
Szegedi, G1
Zeher, M1
Bodolay, E1

Other Studies

1 other study available for sulfasalazine and Right Ventricular Dysfunction

ArticleYear
Diastolic function of the heart in mixed connective tissue disease.
    Clinical rheumatology, 2007, Volume: 26, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclophosphamide; Diastole; Drug Therapy, Comb

2007